Skip to main content

New Releases: Jan 28, 2009


Navigenics this week launched a physician-focused online portal allowing doctors to access the genomic information of consenting patients.

"For patients choosing to receive a Navigenics service through their physician, this portal allows the physician to integrate patients' genetic information into personalized health plans designed to help diagnose early or prevent a number of health conditions," the company said in a statement.

The portal, accessible through Navigenics' website, allows physicians a single access point to all the genomic information of their patients participating in the company's personal genomic service.

Simultaneously, Navigenics also announced it was offering customers a cheaper testing option, called Navigenics Annual Insight, for $499. Navigenics' more comprehensive Health Compass service costs $2,500.

Navigenics' Annual Insight service "mirrors many of the hallmarks of the company's flagship product, Navigenics Health Compass, and provides information on an individual's genetic predisposition for common preventable health conditions," the company said.

For the price, customers receive their genetic risk assessment for nine common diseases; health information developed by the Mayo Clinic and physicians; and one hour of genetic counseling. If more counseling is needed, customers will have to pay an additional fee, the company said.

This new service comes at a slightly higher price point than 23andMe's service, which costs $399. 23andMe last year lowered the price of its service from $999 citing advancements with the Illumina genotyping platform.

Filed under

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.